Point72 Asset Management Establishes 7.7% Stake in AngioDynamics, Inc. (ANGO)

Point72 Asset Management, L.P., along with Point72 Capital Advisors, Inc. and Steven A. Cohen, filed a Schedule 13G/A on May 15, 2026, reporting a 7.7% stake in AngioDynamics, Inc. (ANGO). The filing indicates that the reporting persons beneficially own 3,181,829 shares of common stock as of the event date on March 31, 2026. This represents a significant increase from a previous reported position of zero shares, establishing a new substantial holding in the medical technology company. The shares are held by Point72 Associates, LLC, an investment fund managed by Point72 Asset Management. Steven A. Cohen controls both Point72 Asset Management and Point72 Capital Advisors, Inc., thereby exercising shared voting and dispositive power over the reported shares. Cubist Systematic Strategies, LLC also acted as a sub-advisor for a portion of these shares. The filing was made under Rule 13d-1(c), certifying that the acquisition was for investment purposes and not intended to influence control of the issuer.